ResearcherNankai UniversityNo recent work listed

Juan Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1736-1964; OpenAlex author ID A5107336671. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-022-04542-9 ↗
Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells. Co-author DOI 10.1002/anie.201709744 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chenggang Li · 1 shared paper, 2023 · strength 0.22
- Paper The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-022-04542-9 ↗
Yin Li · 1 shared paper, 2023 · strength 0.22
- Paper The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-022-04542-9 ↗
Yuanjun Sun · 1 shared paper, 2017 · strength 0.06
- Paper Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells. DOI 10.1002/anie.201709744 ↗
Yahui Ding · 1 shared paper, 2017 · strength 0.06
- Paper Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells. DOI 10.1002/anie.201709744 ↗
Yue Chen · 1 shared paper, 2017 · strength 0.06
- Paper Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells. DOI 10.1002/anie.201709744 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.